| For: | Tao J, Xu XS, Song YZ, Qu K, Wu QF, Wang RT, Meng FD, Wei JC, Dong SB, Zhang YL, Tai MH, Dong YF, Wang L, Liu C. Down-regulation of FoxM1 inhibits viability and invasion of gallbladder carcinoma cells, partially dependent on inducement of cellular senescence. World J Gastroenterol 2014; 20(28): 9497-9505 [PMID: 25071344 DOI: 10.3748/wjg.v20.i28.9497] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i28/9497.htm |
| Number | Citing Articles |
| 1 |
Yannasittha Jiramongkol, Eric W.-F. Lam. FOXO transcription factor family in cancer and metastasis. Cancer and Metastasis Reviews 2020; 39(3) doi: 10.1007/s10555-020-09883-w
|
| 2 |
Shou-Hua Wang, Fei Ma, Zhao-hui Tang, Xiao-Cai Wu, Qiang Cai, Ming-Di Zhang, Ming-Zhe Weng, Di Zhou, Jian-Dong Wang, Zhi-Wei Quan. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0436-6
|
| 3 |
Fabian Fischer, Giovanna Grigolon, Christoph Benner, Michael Ristow. Evolutionarily conserved transcription factors as regulators of longevity and targets for geroprotection. Physiological Reviews 2022; 102(3) doi: 10.1152/physrev.00017.2021
|
| 4 |
Changhe Zhang, Ming Yin, Qinghong Liu. The Guidance Impact of Preoperative Magnetic Resonance Cholangiopancreatography on Laparoscopic Cholecystectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques 2015; 25(9) doi: 10.1089/lap.2014.0485
|
| 5 |
Zheng Li, Xin Yu, Jianxiong Shen, Priscilla T.Y. Law, Matthew T.V. Chan, William K.K. Wu. MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer. Oncotarget 2015; 6(16) doi: 10.18632/oncotarget.4227
|
| 6 |
Masato Higurashi, Tsuyoshi Maruyama, Yusuke Nogami, Fumihiro Ishikawa, Yukiko Yoshida, Kazunori Mori, Ken-ichi Fujita, Motoko Shibanuma. High expression of FOXM1 critical for sustaining cell proliferation in mitochondrial DNA-less liver cancer cells. Experimental Cell Research 2020; 389(1) doi: 10.1016/j.yexcr.2020.111889
|
| 7 |
Jie Tao, Xin-Sen Xu, Yan-Zhou Song, Chang Liu. Correction to “Downregulation of FoxM1 inhibits the viability and invasion of gallbladder carcinoma cells, partially dependent on the induction of cellular senescence”. World Journal of Gastroenterology 2021; 27(26) doi: 10.3748/wjg.v27.i26.4241
|
| 8 |
新义 卓. The Effect and Research Progress of FoxM1 in Hepatobiliary System Malignant Tumor. Advances in Clinical Medicine 2021; 11(12) doi: 10.12677/ACM.2021.1112886
|
| 9 |
Weihao Lin, Xin Wang, Zhen Wang, Fei Shao, Yannan Yang, Zheng Cao, Xiaoli Feng, Yibo Gao, Jie He. Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.780461
|
| 10 |
Hao Jin, Min Cui. Recognition of potential therapeutic role of 2‐hydroxy‐3‐methylanthraquinones in the treatment of gallbladder carcinoma: A proteomics analysis. Fundamental & Clinical Pharmacology 2022; 36(2) doi: 10.1111/fcp.12740
|
| 11 |
Jie Tao, Chang Liu, Yan-Zhou Song, Xin-Sen Xu. Correction to “Downregulation of FoxM1 inhibits the viability and invasion of gallbladder carcinoma cells, partially dependent on the induction of cellular senescence”. World Journal of Gastroenterology 2021; 27(26): 4246-4247 doi: 10.3748/wjg.v27.i26.4246
|